ABVC
Price
$0.98
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
26.24M
Intraday BUY SELL Signals
CRSP
Price
$51.72
Change
-$0.54 (-1.03%)
Updated
Sep 11 closing price
Capitalization
5B
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABVC vs CRSP

ABVC vs CRSP Comparison Chart in %
View a ticker or compare two or three
VS
ABVC vs. CRSP commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVC is a Hold and CRSP is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5B) has a higher market cap than ABVC($26.2M). CRSP YTD gains are higher at: -1.373 vs. ABVC (-53.986). ABVC has higher annual earnings (EBITDA): -6.95M vs. CRSP (-515.65M). CRSP has more cash in the bank: 2.36B vs. ABVC (94.4K). ABVC has less debt than CRSP: ABVC (2.62M) vs CRSP (784M). CRSP has higher revenues than ABVC: CRSP (11M) vs ABVC (0).
ABVCCRSPABVC / CRSP
Capitalization26.2M5B1%
EBITDA-6.95M-515.65M1%
Gain YTD-53.986-1.3733,932%
P/E RatioN/AN/A-
Revenue011M-
Total Cash94.4K2.36B0%
Total Debt2.62M784M0%
FUNDAMENTALS RATINGS
ABVC vs CRSP: Fundamental Ratings
ABVC
CRSP
OUTLOOK RATING
1..100
1160
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
7752
P/E GROWTH RATING
1..100
10069
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABVC's Valuation (29) in the null industry is somewhat better than the same rating for CRSP (79) in the Biotechnology industry. This means that ABVC’s stock grew somewhat faster than CRSP’s over the last 12 months.

ABVC's Profit vs Risk Rating (100) in the null industry is in the same range as CRSP (100) in the Biotechnology industry. This means that ABVC’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's SMR Rating (96) in the Biotechnology industry is in the same range as ABVC (98) in the null industry. This means that CRSP’s stock grew similarly to ABVC’s over the last 12 months.

CRSP's Price Growth Rating (52) in the Biotechnology industry is in the same range as ABVC (77) in the null industry. This means that CRSP’s stock grew similarly to ABVC’s over the last 12 months.

CRSP's P/E Growth Rating (69) in the Biotechnology industry is in the same range as ABVC (100) in the null industry. This means that CRSP’s stock grew similarly to ABVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABVCCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (ABVC: $0.98 vs. CRSP: $51.72)
Brand notoriety: ABVC and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVC: 99% vs. CRSP: 60%
Market capitalization -- ABVC: $26.24M vs. CRSP: $5B
ABVC [@Biotechnology] is valued at $26.24M. CRSP’s [@Biotechnology] market capitalization is $5B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVC’s FA Score shows that 1 FA rating(s) are green while CRSP’s FA Score has 0 green FA rating(s).

  • ABVC’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVC is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVC’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • ABVC’s TA Score: 4 bullish, 4 bearish.
  • CRSP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ABVC and CRSP are a good buy in the short-term.

Price Growth

ABVC (@Biotechnology) experienced а +2.08% price change this week, while CRSP (@Biotechnology) price change was -7.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CRSP is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ABVC
Daily Signal:
Gain/Loss:
CRSP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWY286.662.15
+0.76%
iShares Russell Top 200 Growth ETF
UCYB81.290.21
+0.26%
ProShares Ultra Nasdaq Cybersecurity
VSDA57.970.14
+0.25%
VictoryShares Dividend Accelerator ETF
SURE146.99N/A
N/A
AdvisorShares Insider Advantage ETF
FXU46.45-0.21
-0.45%
First Trust Utilities AlphaDEX® ETF

ABVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVC has been loosely correlated with KNSA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVC jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVC
1D Price
Change %
ABVC100%
+0.40%
KNSA - ABVC
40%
Loosely correlated
-0.27%
EDIT - ABVC
37%
Loosely correlated
+1.89%
IONS - ABVC
36%
Loosely correlated
-2.59%
CRSP - ABVC
32%
Poorly correlated
-1.03%
MLEC - ABVC
31%
Poorly correlated
-5.00%
More